Peer-reviewed journal articles (260)
72.
Ferdinande, L., Decaestecker, C., Verset, L., Mathieu, A., Moles Lopez, X., Negulescu, A., Van Maerken, T., Salmon, I., Cuvelier, C. A., & Demetter, P. (2012). Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer. British Journal of Cancer, 106(1), 141-147. doi:10.1038/bjc.2011.51374.
Duray, A., Descamps, G., Arafa, M., Decaestecker, C., Remmelink, M., Sirtaine, N., Ernoux-Neufcoeur, P., Mutijima, E., Somja, J., Depuydt, C. E., Delvenne, P. O., & Saussez, S. (2011). High incidence of high-risk HPV in benign and malignant lesions of the larynx. International journal of oncology, 39(1), 51-59. doi:10.3892/ijo.2011.103175.
Remmelink, M., de Leval, L., Decaestecker, C., Duray, A., Crompot, E., Sirtaine, N., André, S., Kaltner, H., Leroy, X., Gabius, H.-J., & Saussez, S. (2011). Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: divergent profiles with diagnostic potential. Histopathology, 58(4), 543-556. doi:10.1111/j.1365-2559.2011.03776.x76.
Ernoux-Neufcoeur, P., Arafa, M., Decaestecker, C., Duray, A., Remmelink, M., Leroy, X., Herfs, M., Somja, J., Depuydt, C. E., Delvenne, P. O., & Saussez, S. (2011). Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. Journal of cancer research and clinical oncology, 137(1), 173-181. doi:10.1007/s00432-010-0871-277.
Rorive, S., Moles Lopez, X., Maris, C., Trepant, A.-L., Sauvage, S., Sadeghi-Meibodi, N., Roland, I., Decaestecker, C., & Salmon, I. (2010). TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas. Modern pathology, 23(10), 1418-1428. doi:10.1038/modpathol.2010.13678.
Cludts, S., Decaestecker, C., Johnson, B., Lechien, J., Leroy, X., Kindt, N., Kaltner, H., André, S., Gabius, H.-J., & Saussez, S. (2010). Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. Anticancer research, 30(9), 3313-3319.79.
Le Calve, B., Rynkowski, M., Le Mercier, M., Bruyère, C., Lonez, C., Gras, T., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Ruysschaert, J. M., Kiss, R., & Lefranc, F. (2010). Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia (New York, N.Y.), 12(9), 727-739. doi:10.1593/neo.1052680.
Balde, E. S., Megalizzi, V., Traoré, M. S., Cos, P., Maes, L., Decaestecker, C., Pieters, L., & Balde, A. (2010). In vitro antiprotozoal, antimicrobial and antitumor activity of Pavetta crassipes K. Schum leaf extracts. Journal of ethnopharmacology, 130(3), 529-535. doi:10.1016/j.jep.2010.05.04281.
Rorive, S., D'Haene, N., Fossion, C., Delpierre, I., Abarguia, N., Avni, E., Decaestecker, C., & Salmon, I. (2010). Ultrasound-guided fine-needle aspiration of thyroid nodules: stratification of malignancy risk using follicular proliferation grading, clinical and ultrasonographic features. European journal of endocrinology, 162(6), 1107-1115. doi:10.1530/EJE-09-110382.
Mancilla, V., Decaestecker, C., Ligny, C., Matagne, L., Simon, P., & Courtmans, I. (2010). La surdité moyenne: Étiologie, évaluation linguistique et scolaire. Cahiers de l'audition, 23(3), 5-9.